City
Epaper

India gets largest PE investment in healthcare sector in Asia-Pacific region during 2024: Report

By ANI | Updated: April 23, 2025 11:42 IST

New Delhi [India], April 23 : With 26 per cent of the deal volume, India has emerged as the ...

Open in App

New Delhi [India], April 23 : With 26 per cent of the deal volume, India has emerged as the largest private equity buyout in the healthcare sector in the Asia-Pacific region in 2024, said a report by the global private investment firm Bain and Capital.

The wider Asia-Pacific market, however, grapples with a decline in buyout activity, with regional volumes plummeting by nearly 49 per cent.

"India also appears more resilient to deal downturns than other countries in the region, with buyout volumes dipping only 18 per cent from 2023, vs. a nearly 49 percent drop across Asia-Pacific overall", said the report

This growth can be attributed to a combination of buoyant capital markets, strong economic fundamentals, and a burgeoning investor confidence, fuelled by successful private equity exits, such as Advent International's USD 1.6 billion sale of BSV Group to Mankind Pharma.

"Successful PE exits with strong returns, such as Advent International's USD 1.6 billion sale of BSV Group to Mankind Pharma, have also validated India's buyout market, making it more attractive for future investment," the report added.

Strong growth is projected to continue in India's healthcare sector, with healthcare spending expected to reach USD 320 billion by 2028.

In India, over the past two years, investments have come in the provider and related services space and biopharma and related services, with a sharper focus on provider deals. In the provider space, investments have gravitated to hospitals, clinics, and supporting services.

The report highlighted that the India has consistently delivered favourable returns and has enabled a range of successful exits for PE firms through initial public offerings (boosted by strong public markets), strategic acquisitions (bolstered by acquirers' strong balance sheets), and sponsor-to-sponsor deals (such as KKR's USD 839 million acquisition of Healthium Medtech from Apax Funds).

"With a proven track record, favourable macroeconomic conditions, and a diverse healthcare landscape, India is expected to remain a prime investment location for PE firms," the report added.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

EntertainmentElizabeth Banks to essay lead in a limited series about murder trial

International"Trump's tariffs an exercise in power but will weaken America": Former MoS MJ Akbar

Other Sports"India ready to host global sporting events": Mansukh Mandaviya on bid for Commonwealth Games 2030 in Ahmedabad

EntertainmentSalman Khan shares glimpses of Khan family’s Ganpati celebrations

Other SportsPCI President Devendra Jhajharia explains importance of Mondo track in preparation for LA 2028 Paralympics

Business Realted Stories

BusinessAirtel announces emergency connectivity support amid heavy rains in J&K, Ladakh and Himachal

BusinessGovt focused on creating next-gen infra, empowering street vendors: PM Modi

BusinessCentre backs plan to bolster civil aviation in eastern states

BusinessGovt, private sector can keep tariff disruptions to a minimum: FinMin Economic Review

BusinessZupee rules out legal action against Online Gaming Law, stays committed to building Social Games and Entertainment Avenues